Dolor neuropático y su tratamiento

-
Revisión sistemática y meta-análisis

Lancet Neurol 2015; January 7: 162–73

Interpretation: Our results support a revision of the NeuPSIG recommendations for the pharmacotherapy of neuropathic pain. Inadequate response to drug treatments constitutes a substantial unmet need in patients with neuropathic pain. Modest efficacy, large placebo responses, heterogeneous diagnostic criteria, and poor phenotypic profiling probably account for moderate trial outcomes and should be taken into account in future studies.

Comentarios

Publicar un comentario

Entradas populares de este blog

Acrometastasis

-
Imagen
N Engl J Med 2011; 365:e38 November 3, 2011 Revisión de la literatura Pueden revisar el tema en:  http://www.europeanreview.org/wp/wp-content/uploads/2906-2915.pdf http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582515/pdf/co15-5-227e51.pdf
Leer más

Vitamina C Intravenosa en Cáncer. Realmente funciona y mejora la calidad de vida??

-
Imagen
There is weak evidence that ascorbate given intravenously may improve the quality of life of cancer patients and reduce the toxicity of chemotherapy.  We have identified potential serious toxicity of intravenous ascorbate.  TheOncologist2015;20:210–223 Preliminary evidence suggests that IVC may have the potential to improve tumor response and survival time, as well as improve QOL and side effects of chemotherapy or cancer-related symptoms; however, there is an urgent need for rigorous and well-controlled evaluations of IVC as an adjunctive treatment for cancer before definite conclusions can be drawn. I ntegrative Cancer Therapies 2014, Vol. 13(4) 280–300 Información completa en los enlaces: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319640/pdf/theoncologist_14381.pdf https://app.box.com/s/9kl7z3bdh1tpy7bjd6yeir3iv4les8cq
Leer más